EXUMA Biotech to Present at the 2022 Cancer Immunology and Immunotherapy Conference and to Participate in the 7th Annual CAR-TCR Summit
- Friday, September 16, 2022, 7:04
- Finance
- Add a comment
WEST PALM BEACH, Fla., Sept. 16, 2022 /PRNewswire/ — EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological tumors, announced that pre-clinical data from its solid-tumor subcutaneous CAR therapy…
About the Author
adminasapcorp has written 42190 stories on this site.